Mark Prentice

1.1k total citations
16 papers, 362 citations indexed

About

Mark Prentice is a scholar working on Pulmonary and Respiratory Medicine, Nuclear and High Energy Physics and Radiation. According to data from OpenAlex, Mark Prentice has authored 16 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 4 papers in Nuclear and High Energy Physics and 3 papers in Radiation. Recurrent topics in Mark Prentice's work include Prostate Cancer Treatment and Research (8 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Particle physics theoretical and experimental studies (4 papers). Mark Prentice is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Particle physics theoretical and experimental studies (4 papers). Mark Prentice collaborates with scholars based in United Kingdom, Switzerland and Sweden. Mark Prentice's co-authors include Nicolas Mottet, Lore Decoster, G. Von Dardel, Karim Fizazi, J. M. Weiss, Heather Payne, P.S.L. Booth, G. Damgaard, Martine Puts and P. Jackson and has published in prestigious journals such as Journal of Clinical Oncology, Nuclear Physics B and Physics Letters B.

In The Last Decade

Mark Prentice

15 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Prentice United Kingdom	6	196	108	45	28	26	16	362
S. Bhattacharyya India	11	162 0.8×	56 0.5×	53 1.2×	7 0.3×	11 0.4×	97	447
A. Serrano Mexico	10	59 0.3×	20 0.2×	18 0.4×	18 0.6×	10 0.4×	48	344
Claudia Schumacher Germany	13	49 0.3×	82 0.8×	216 4.8×	34 1.2×	15 0.6×	53	426
Seung Soo Hong South Korea	11	63 0.3×	50 0.5×	67 1.5×	11 0.4×	12 0.5×	70	417
Junya Shirai Japan	14	74 0.4×	274 2.5×	125 2.8×	19 0.7×	16 0.6×	45	617
Meng-Lin Huang China	12	14 0.1×	47 0.4×	119 2.6×	27 1.0×	20 0.8×	31	409
Sander van Doorn Netherlands	12	21 0.1×	33 0.3×	30 0.7×	48 1.7×	16 0.6×	40	558
Maohuan Lin China	9	43 0.2×	12 0.1×	16 0.4×	7 0.3×	4 0.2×	12	297
Harushi Ueno Japan	8	51 0.3×	77 0.7×	52 1.2×	28 1.0×	2 0.1×	75	287

Countries citing papers authored by Mark Prentice

Since Specialization

Citations

This map shows the geographic impact of Mark Prentice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Prentice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Prentice more than expected).

Fields of papers citing papers by Mark Prentice

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Prentice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Prentice. The network helps show where Mark Prentice may publish in the future.

Co-authorship network of co-authors of Mark Prentice

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Prentice. A scholar is included among the top collaborators of Mark Prentice based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Prentice. Mark Prentice is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Bahl, Amit, Amarnath Challapalli, Prantik Das, et al.. (2025). Prospective real world data evaluation of clinical outcomes in metastatic hormone sensitive prostate cancer (MHSPC) patients treated as part of triplet therapy with darolutamide: UK multicenter RECOMMEND study.. Journal of Clinical Oncology. 43(5_suppl). 89–89.

Augustin, Marinela, Brigitte Laguerre, Capucine Baldini, et al.. (2024). Pembrolizumab (pembro) plus lenvatinib (lenva) in patients (pts) with docetaxel-pretreated, metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort E.. Journal of Clinical Oncology. 42(4_suppl). 148–148. 1 indexed citations

Alibhai, Shabbir M.H., Lore Decoster, Eleni Efstathiou, et al.. (2019). Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients. European Journal of Cancer. 116. 116–136. 136 indexed citations

Orczyk, Clément, Mark Prentice, Manit Arya, et al.. (2019). Late toxicity described using patient reported outcomes measures (PROMS) in men treated with salvage radiation following primary high intensity focal ultrasound (HIFU) for localized prostate cancer.. Journal of Clinical Oncology. 37(7_suppl). 131–131. 1 indexed citations

Prentice, Mark, et al.. (2018). Brachytherapy in prostate cancer: techniques and clinical outcomes. Trends in Urology & Men s Health. 9(1). 19–24. 1 indexed citations

Prentice, Mark, et al.. (2018). Radiotherapy in elderly patients with prostate cancer. Trends in Urology & Men s Health. 9(4). 13–17. 1 indexed citations

Prentice, Mark, et al.. (2018). Patterns of therapy in pelvic lymph node positive prostate cancer in Europe and Asia: A real-world data analysis. Annals of Oncology. 29. viii296–viii296. 1 indexed citations

Prentice, Mark, Wen Long Nei, Clément Orczyk, et al.. (2017). Late Toxicity and Patient Reported Outcomes in Patients Treated With Salvage Radiation Following Primary High Intensity Focal Ultrasound for Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 99(2). E226–E226. 1 indexed citations

Scrimgeour, Euan M., et al.. (1996). Toxocaracontrol: Failure of dog‐owners to carry out regular deworming of their pets. International Journal of Environmental Health Research. 6(1). 27–30. 2 indexed citations

10.

Prentice, Mark. (1995). Other end of the bedpan.. PubMed. 9(37). 56–56. 3 indexed citations

11.

Prentice, Mark, et al.. (1989). Ectopic ß-human chorionic gonadotropin production by a dermoid cyst. American Journal of Obstetrics and Gynecology. 160(2). 449–451. 4 indexed citations

12.

Millingen, Keith S. & Mark Prentice. (1987). Isolated unilateral hypoglossal nerve palsy due to a chondroid chordoma.. PubMed. 23. 213–7. 5 indexed citations

13.

Alper, B., H. Bøggild, P.S.L. Booth, et al.. (1975). The production of charged particles with high transverse momentum in proton-proton collisions at the CERN ISR. Nuclear Physics B. 87(1). 19–40. 84 indexed citations

14.

Alper, B., H. Bøggild, P.S.L. Booth, et al.. (1973). Large-angle inclusive production of protons, antiprotons and kaons, and particle composition at the CERN ISR. Physics Letters B. 47(3). 275–280. 32 indexed citations

15.

Alper, B., H. Bøggild, P.S.L. Booth, et al.. (1973). Large-angle inclusive production of charged pions at the CERN ISR with transverse moment a less than 1.0 GeV/c. Physics Letters B. 47(1). 75–79. 45 indexed citations

16.

Alper, B., P.S.L. Booth, F. Bulos, et al.. (1973). Large angle production of stable particles heavier than the proton and a search for quarks at the CERN intersecting storage rings. Physics Letters B. 46(2). 265–268. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact